US Bancorp DE boosted its stake in shares of Henry Schein Inc. (NASDAQ:HSIC) by 0.5% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 58,009 shares of the company’s stock after buying an additional 306 shares during the period. US Bancorp DE owned about 0.07% of Henry Schein worth $9,454,000 at the end of the most recent quarter.

Several other hedge funds have also recently bought and sold shares of HSIC. Exxonmobil Investment Management Inc. TX increased its stake in Henry Schein by 6.5% in the second quarter. Exxonmobil Investment Management Inc. TX now owns 21,243 shares of the company’s stock valued at $3,756,000 after buying an additional 1,292 shares during the last quarter. Chevy Chase Trust Holdings Inc. boosted its position in shares of Henry Schein by 4.0% in the second quarter. Chevy Chase Trust Holdings Inc. now owns 223,907 shares of the company’s stock valued at $39,587,000 after buying an additional 8,624 shares during the period. Creative Planning boosted its position in shares of Henry Schein by 20.5% in the second quarter. Creative Planning now owns 6,526 shares of the company’s stock valued at $1,154,000 after buying an additional 1,110 shares during the period. Neville Rodie & Shaw Inc. boosted its position in shares of Henry Schein by 9.6% in the second quarter. Neville Rodie & Shaw Inc. now owns 43,660 shares of the company’s stock valued at $7,719,000 after buying an additional 3,820 shares during the period. Finally, Capstone Asset Management Co. boosted its position in shares of Henry Schein by 11.2% in the second quarter. Capstone Asset Management Co. now owns 10,774 shares of the company’s stock valued at $1,905,000 after buying an additional 1,089 shares during the period. 91.35% of the stock is owned by institutional investors and hedge funds.

Institutional Ownership by Quarter for Henry Schein (NASDAQ:HSIC)

Henry Schein Inc. (NASDAQ:HSIC) traded down 2.86% during midday trading on Wednesday, hitting $148.85. The company had a trading volume of 637,846 shares. The stock has a market cap of $11.98 billion, a price-to-earnings ratio of 24.72 and a beta of 1.09. Henry Schein Inc. has a 12-month low of $142.64 and a 12-month high of $183.00. The company’s 50 day moving average is $154.22 and its 200 day moving average is $166.36.

Henry Schein (NASDAQ:HSIC) last announced its quarterly earnings data on Wednesday, November 2nd. The company reported $1.68 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.65 by $0.03. Henry Schein had a net margin of 4.40% and a return on equity of 18.15%. The business had revenue of $2.87 billion for the quarter, compared to analyst estimates of $2.88 billion. During the same period in the prior year, the business posted $1.55 earnings per share. Henry Schein’s revenue was up 6.7% compared to the same quarter last year. On average, equities analysts anticipate that Henry Schein Inc. will post $6.58 EPS for the current fiscal year.

COPYRIGHT VIOLATION WARNING: “US Bancorp DE Raises Position in Henry Schein Inc. (HSIC)” was first published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this piece on another website, it was copied illegally and republished in violation of United States and international copyright and trademark law. The original version of this piece can be read at https://www.thecerbatgem.com/2016/11/30/us-bancorp-de-raises-position-in-henry-schein-inc-hsic.html.

Several equities analysts recently issued reports on HSIC shares. Zacks Investment Research cut Henry Schein from a “hold” rating to a “sell” rating in a research report on Monday, August 8th. Bank of America Corp. started coverage on Henry Schein in a research report on Monday, September 12th. They issued a “buy” rating and a $185.00 price target on the stock. Leerink Swann restated a “hold” rating on shares of Henry Schein in a research report on Thursday, November 3rd. Robert W. Baird restated an “outperform” rating and issued a $176.00 price target (up previously from $175.00) on shares of Henry Schein in a research report on Tuesday, October 4th. Finally, JPMorgan Chase & Co. restated a “hold” rating and issued a $163.00 price target on shares of Henry Schein in a research report on Thursday, November 3rd. Seven analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. Henry Schein presently has a consensus rating of “Hold” and a consensus price target of $172.83.

In related news, EVP Mark E. Mlotek sold 2,417 shares of the stock in a transaction that occurred on Thursday, November 3rd. The shares were sold at an average price of $155.19, for a total value of $375,094.23. Following the transaction, the executive vice president now directly owns 40,456 shares in the company, valued at $6,278,366.64. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 1.27% of the stock is currently owned by corporate insiders.

About Henry Schein

Henry Schein, Inc is a provider of health care products and services to office-based dental, animal health and medical practitioners. The Company’s segments include healthcare distribution, and technology and value-added services. The healthcare distribution segment aggregates its global dental, animal health and medical operating segments.

5 Day Chart for NASDAQ:HSIC

Receive News & Stock Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related stocks with our FREE daily email newsletter.